Drug Profile
PRAK 03202
Alternative Names: Coronavirus vaccine - Akers Biosciences/Premas Biotech; PRAK-03202; PRAK3202Latest Information Update: 31 Aug 2020
Price :
$50
*
At a glance
- Originator Premas Biotech
- Class Peptide vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical COVID 2019 infections
Most Recent Events
- 27 Aug 2020 Premas Biotech announces intention to submit IND application to the US FDA and Drugs Controller General of India for COVID-2019 infections
- 27 Aug 2020 Adverse events and pharmacodynamics data from preclinical trials in COVID-19 infections released by Premas Biotech
- 07 Jul 2020 Preclinical trials in COVID-2019 infections in India (IM)